Filing Flows › cbdMD (YCBD) › Q2 FY26
cbdMD (YCBD) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed May 14, 2026
cbdMD (YCBD) reported revenue of $5.6M for the second quarter fiscal 2026 (Q2 FY26), +19% from a year earlier and +12% from the quarter before. Operating margin was -14.2%, net loss $798K (14.1% of revenue).
cbdMD, Q2 FY26: revenue $5.6M (+19% year over year), operating margin -14.2%, net loss $798K, operating cash flow −$722K. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.6M | +12% | +19% |
| Operating profit | −$801K | — | — |
| Net earnings | −$798K | — | — |
| Operating cash flow | −$722K | — | — |
What changed
Revenue was $5.6M in Q2 FY26, up 19% year over year and up 12% from the previous quarter.
Gross margin was 57.7%, down 4.6 points from Q2 FY25. Operating costs exceeded revenue by $801K, an operating margin of -14.2%. Operating expenses grew 18% against revenue growth of 19%. The quarter ended with a net loss of $798K, wider than the previous quarter's $283K loss.
Operating cash flow was −$722K. Non-cash charges added back $252K of depreciation and amortization. Working capital and other items used $176K. Capital expenditures of $6K exceeded it, leaving free cash flow of −$728K.
Questions
What was cbdMD's revenue in the second quarter fiscal 2026?
cbdMD (YCBD) reported revenue of $5.6M for the second quarter fiscal 2026 (Q2 FY26), +19% from a year earlier and +12% from the quarter before.
Was cbdMD profitable in the second quarter fiscal 2026?
Operating loss was $801K (-14.2% of revenue) and net loss $798K.
Source: cbdMD 10-Q on SEC EDGAR.